Augmentation of ADAMTS9 gene expression by IL-1β is reversed by NFκB and MAPK inhibitors, but not PI3 kinase inhibitors. [electronic resource]
Producer: 20140509Description: 539-44 p. digitalISSN:- 1099-0844
- ADAM Proteins -- genetics
- ADAMTS9 Protein
- Gene Expression Regulation -- drug effects
- Humans
- Interleukin-1beta -- genetics
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- NF-kappa B -- antagonists & inhibitors
- Phosphatidylinositol 3-Kinases -- genetics
- Phosphoinositide-3 Kinase Inhibitors
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.